Cumberland Pharmaceuticals (CPIX) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to $0.2.
- Cumberland Pharmaceuticals' Debt to Equity fell 6910.36% to $0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.2, marking a year-over-year decrease of 6910.36%. This contributed to the annual value of $0.67 for FY2024, which is 5478.63% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Debt to Equity stood at $0.2 for Q3 2025, which was down 6910.36% from $0.19 recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Debt to Equity ranged from a high of $0.67 in Q4 2024 and a low of $0.18 during Q1 2025
- For the 5-year period, Cumberland Pharmaceuticals' Debt to Equity averaged around $0.41, with its median value being $0.43 (2023).
- Its Debt to Equity has fluctuated over the past 5 years, first soared by 8086.17% in 2024, then crashed by 6934.11% in 2025.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Debt to Equity stood at $0.35 in 2021, then rose by 27.5% to $0.45 in 2022, then decreased by 3.32% to $0.43 in 2023, then soared by 54.79% to $0.67 in 2024, then plummeted by 69.98% to $0.2 in 2025.
- Its last three reported values are $0.2 in Q3 2025, $0.19 for Q2 2025, and $0.18 during Q1 2025.